...
机译:药物洗脱支架与冠状动脉旁路接枝的经皮冠状动脉干预:左主冠状动脉疾病患者的META分析
Department of Cardiology East and North Hertfordshire NHS Trust;
Department of Cardiology East and North Hertfordshire NHS Trust;
Department of Cardiology East and North Hertfordshire NHS Trust;
Department of Cardiovascular Diseases Mayo Clinic;
Department of Cardiology East and North Hertfordshire NHS Trust;
Department of Cardiology East and North Hertfordshire NHS Trust;
Postgraduate Medical School University of Hertfordshire;
Cochrane Advisory Group Postgraduate Medical School Ain Shams University;
Department of Cardiology East and North Hertfordshire NHS Trust;
Left main stem; Coronary artery disease; Percutaneous coronary intervention; Coronary artery bypass grafting;
机译:经皮冠状动脉介入治疗无保护的左主冠状动脉的眼部/中轴病变与远端分叉病变的长期临床结果:DELTA Registry(左主冠状动脉疾病药物洗脱支架):评估经皮冠状动脉介入治疗的多中心注册表与冠状动脉搭桥术进行左主治疗
机译:药物洗脱支架与冠状动脉旁路接枝的经皮冠状动脉干预:左主冠状动脉疾病患者的META分析
机译:药物洗脱支架与冠状动脉旁路接枝的经皮冠状动脉干预:左主冠状动脉疾病患者的META分析
机译:Euroscore和我们的风险预测模型用于冠状动脉旁路冠状动脉左右疾病的冠状动脉旁路移植的外科和全因导致死亡率
机译:比较40岁以下的患者和40岁以上进行冠状动脉搭桥术的患者的术前选择的冠心病危险因素。
机译:使用药物洗脱支架的经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干冠状动脉疾病的最新荟萃分析
机译:经皮冠状动脉介入治疗未受保护的左冠状动脉主干/中轴病变与远端分叉病变的长期临床结果DELTA Registry(评估左冠状动脉主要疾病的药物洗脱支架):评估经皮冠状动脉介入治疗的多中心注册表冠状动脉旁路移植术治疗左主干